|
STAU2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.515800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.125200E-01 |
| Normal-vs-Stage2 |
2.038600E-01 |
| Normal-vs-Stage3 |
5.141600E-01 |
| Normal-vs-Stage4 |
6.692600E-01 |
| Stage1-vs-Stage2 |
3.090400E-01 |
| Stage1-vs-Stage3 |
6.297200E-01 |
| Stage1-vs-Stage4 |
8.341400E-01 |
| Stage2-vs-Stage3 |
6.420600E-01 |
| Stage2-vs-Stage4 |
5.991400E-01 |
| Stage3-vs-Stage4 |
9.219800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.909400E-01 |
| Normal-vs-AfricanAmerican |
4.519200E-01 |
| Normal-vs-Asian |
4.042200E-01 |
| Caucasian-vs-AfricanAmerican |
8.980800E-01 |
| Caucasian-vs-Asian |
4.187000E-01 |
| AfricanAmerican-vs-Asian |
2.930800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.831200E-01 |
| Normal-vs-Female |
1.693590E-02 |
| Male-vs-Female |
3.644200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.941200E-01 |
| Normal-vs-Extreme_Weight |
7.548400E-01 |
| Normal-vs-Obese |
2.952200E-01 |
| Normal-vs-Extreme_Obese |
4.530600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.758000E-01 |
| Normal_Weight-vs-Obese |
8.054800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.858400E-01 |
| Extreme_Weight-vs-Obese |
2.529800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.809200E-01 |
| Obese-vs-Extreme_Obese |
7.437600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.035200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.664200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.866400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.671600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.967200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.767600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.042000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.553600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.023000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.328800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.626600E-01 |
| Normal-VS-Type2 PRCC |
9.102000E-01 |
| Normal-VS-KIRP CIMP |
6.286200E-01 |
| Normal-VS-Unclassified PRCC |
6.113200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.639800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.934000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.473000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.611000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.042000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.536600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.258200E-01 |
| Normal-vs-N1 |
1.531430E-01 |
| Normal-vs-N2 |
9.409600E-01 |
| N0-vs-N1 |
8.598400E-02 |
| N0-vs-N2 |
7.623800E-01 |
| N1-vs-N2 |
5.379600E-01 |
|
|
